JNJ

224.16

-1.45%↓

UNH

370.76

+0.47%↑

TMO

462.35

-1.48%↓

ISRG

452.39

-1.14%↓

ABT

87.56

-2.18%↓

JNJ

224.16

-1.45%↓

UNH

370.76

+0.47%↑

TMO

462.35

-1.48%↓

ISRG

452.39

-1.14%↓

ABT

87.56

-2.18%↓

JNJ

224.16

-1.45%↓

UNH

370.76

+0.47%↑

TMO

462.35

-1.48%↓

ISRG

452.39

-1.14%↓

ABT

87.56

-2.18%↓

JNJ

224.16

-1.45%↓

UNH

370.76

+0.47%↑

TMO

462.35

-1.48%↓

ISRG

452.39

-1.14%↓

ABT

87.56

-2.18%↓

JNJ

224.16

-1.45%↓

UNH

370.76

+0.47%↑

TMO

462.35

-1.48%↓

ISRG

452.39

-1.14%↓

ABT

87.56

-2.18%↓

Search

AdaptHealth Corp

Geschlossen

BrancheGesundheitswesen

13.19 0.15

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

13.05

Max

13.28

Schlüsselkennzahlen

By Trading Economics

Einkommen

-124M

-102M

Verkäufe

26M

846M

KGV

Branchendurchschnitt

17.527

67.147

Gewinnspanne

-11.998

Angestellte

10,900

EBITDA

-147M

24M

Empfehlungen

By TipRanks

Empfehlungen

Buy

12-Monats-Prognose

-6.61% downside

Dividenden

By Dow Jones

Nächstes Ergebnis

5. Mai 2026

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

384M

1.8B

Vorheriger Eröffnungskurs

13.04

Vorheriger Schlusskurs

13.19

Nachrichtenstimmung

By Acuity

68%

32%

46 / 347 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Bullish Evidence

AdaptHealth Corp Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

4. Mai 2026, 22:17 UTC

Ergebnisse

Australia's Westpac Lifts Dividend as 1st Half Profit Rises 2.7%

4. Mai 2026, 23:47 UTC

Ergebnisse

Grab Holdings 1Q Adj EBITDA $154.0M Vs. $106.0M >GRAB

4. Mai 2026, 23:45 UTC

Ergebnisse

Grab Holdings 1Q Rev $955.0M Vs. $773.0M >GRAB

4. Mai 2026, 23:45 UTC

Ergebnisse

Grab Holdings 1Q Net $120.0M Vs. Net $10.0M >GRAB

4. Mai 2026, 23:40 UTC

Market Talk

Gold Steady Amid Likely Technical Recovery -- Market Talk

4. Mai 2026, 22:44 UTC

Akquisitionen, Fusionen, Übernahmen

Regis: Jim Beyer To Be Chief Executive of Combined Company

4. Mai 2026, 22:43 UTC

Akquisitionen, Fusionen, Übernahmen

Regis: Russell Clark To Be Nonexecutive Chairman of Combined Company

4. Mai 2026, 22:42 UTC

Akquisitionen, Fusionen, Übernahmen

Regis: Companies Expect to Realize Over A$500 Million in Corporate Tax Benefits

4. Mai 2026, 22:42 UTC

Akquisitionen, Fusionen, Übernahmen

Regis: Combined Company to Have Strong, Debt-Free Balance Sheet; Significant Cash Generation

4. Mai 2026, 22:41 UTC

Akquisitionen, Fusionen, Übernahmen

Regis: Combined Company to Have Annual Production of More Than 700,000 Oz

4. Mai 2026, 22:41 UTC

Akquisitionen, Fusionen, Übernahmen

Regis: Pro Forma Market Capitalization About A$10.7 Billion

4. Mai 2026, 22:40 UTC

Akquisitionen, Fusionen, Übernahmen

Regis: Shareholders to Own About 51% of Combined Company

4. Mai 2026, 22:40 UTC

Akquisitionen, Fusionen, Übernahmen

Regis: Board Unanimously Endorsed, Supported Deal

4. Mai 2026, 22:40 UTC

Akquisitionen, Fusionen, Übernahmen

Regis: Deal Unanimously Recommended by Vault Board

4. Mai 2026, 22:39 UTC

Akquisitionen, Fusionen, Übernahmen

Regis: Vault Shareholders to Receive 0.6947 New Shares in Regis For Each Vault One Held

4. Mai 2026, 22:38 UTC

Akquisitionen, Fusionen, Übernahmen

Regis Resources to Acquire All Ordinary Shares in Vault

4. Mai 2026, 22:38 UTC

Akquisitionen, Fusionen, Übernahmen

Regis Resources, Vault Minerals Agree to Merger of Equals

4. Mai 2026, 22:37 UTC

Ergebnisse
Akquisitionen, Fusionen, Übernahmen

Palantir Beats Forecasts With $1.63 Billion Quarter as Sales Accelerate -- 2nd Update

4. Mai 2026, 22:26 UTC

Ergebnisse
Akquisitionen, Fusionen, Übernahmen

Palantir Beats Forecasts With $1.63 Billion Quarter as Sales Accelerate -- Update

4. Mai 2026, 22:02 UTC

Ergebnisse

Australia's Westpac Lifts Dividend as 1H Profit Rises 2.7%

4. Mai 2026, 22:00 UTC

Market Talk

BOC's Macklem: Conditions To Dictate Fuel-Price Response -- Market Talk

4. Mai 2026, 21:52 UTC

Ergebnisse

Westpac 1H Net Profit Ex-Notable Items A$3.48B Vs. A$3.46B>WBC.AU

4. Mai 2026, 21:50 UTC

Ergebnisse

Westpac: Some Sectors More Affected Than Others>WBC.AU

4. Mai 2026, 21:50 UTC

Ergebnisse

Westpac: Economic Impact of Middle East Conflict to Continue Through Year>WBC.AU

4. Mai 2026, 21:49 UTC

Ergebnisse

Westpac 1H Provision for Expected Credit Losses A$4.68B Vs. A$4.58B>WBC.AU

4. Mai 2026, 21:44 UTC

Ergebnisse

Westpac 1H Australia Lending Up 8% on Year>WBC.AU

4. Mai 2026, 21:44 UTC

Ergebnisse

Westpac 1H Australia Business Lending Up 16% on Year>WBC.AU

4. Mai 2026, 21:43 UTC

Ergebnisse

Westpac 1H Core Net Interest Margin 1.78% Vs. 1.80%>WBC.AU

4. Mai 2026, 21:41 UTC

Ergebnisse

Westpac 1H Australian Home Lending Up 7% on Year Excluding RAMS Portfolio>WBC.AU

4. Mai 2026, 21:40 UTC

Ergebnisse

Westpac 1H Credit Impairment Charge 10 Bps of Average Loans Vs. 6 Bps>WBC.AU

Peer-Vergleich

Kursveränderung

AdaptHealth Corp Prognose

Kursziel

By TipRanks

-6.61% Nachteil

12-Monats-Prognose

Durchschnitt 12.3 USD  -6.61%

Hoch 14 USD

Tief 9.5 USD

Basierend auf 5 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für AdaptHealth Corp – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

5 ratings

3

Buy

2

Halten

0

Sell

Technischer Score

By Trading Central

7.95 / 8.505Unterstützung & Widerstand

Kurzfristig

Bullish Evidence

Mittelfristig

Strong Bearish Evidence

Langfristig

Strong Bearish Evidence

Stimmung

By Acuity

46 / 347 Ranking in Gesundheitswesen

Nachrichtenstimmung

Bärische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Durchschnitt

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über AdaptHealth Corp

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs. It also offers wheelchairs, hospital beds, oxygen concentrators, CPAP masks and related supplies, wound care supplies, diabetes management supplies, wheelchair cushion accessories, orthopedic bracing, breast pumps and supplies, walkers, commodes and canes, and nutritional and incontinence supplies. The company services beneficiaries of Medicare, Medicaid, and commercial insurance payors. The company is headquartered in Plymouth Meeting, Pennsylvania.
help-icon Live chat